Glaxosmithkline | Ventas

Precio De Mercado
60.84
Cambio Diario
12.55 25.99%
Mensual
24.90%
Anual
66.18%
Q1 Expectativa
57.76




Ventas Cambio Fecha
AbbVie USD 16.62B 840M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Aurora Cannabis CAD 90.37M 7.65M 2025-09
Bausch Health Companies USD 2.68B 150M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Canopy Growth CAD 66.68M 5.45M 2025-09
Corcept Therapeutics USD 207.6M 13.2M 2025-09
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Glaxosmithkline GBP 11.52B 3.54B 2025-09
J&J USD 24.6B 610M 2025-12
Merck USD 16.4B 880M 2025-12
Novartis USD 13.91B 144M 2025-09
Pacira USD 179.52M 1.58M 2025-09
Perrigo USD 1.04B 16.3M 2025-09
Pfizer USD 17.58B 880M 2025-12
Phibro Animal Health USD 309.26M 48.83M 2024-12
Prestige Brands USD 283.44M 9.34M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Supernus Pharmaceuticals USD 192.1M 26.6M 2025-09
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Zoetis USD 2.4B 0 2025-12


Glaxosmithkline Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.